Washington, D.C.’s medical marijuana market generated a record $10.79 million in sales during October, bringing the district’s total for the first 10 months of 2026 to nearly $99 million.
The $10,785,487 generated in October represents a 5.3% increase from September’s $10,245,823 and a 20.4% increase from the $8,960,855 reported in October 2025, according to new data from the district’s Alcoholic Beverage and Cannabis Administration.
Through October, combined medical marijuana sales have reached $99,845,126 in 2026. October was the strongest month of the year, surpassing the previous high of approximately $10.61 million recorded in July. With two months remaining, the market is already within about $2 million of the $100.9 million generated throughout all of 2025.
Licensed dispensaries accounted for $6,748,855 of October’s total, a 16.8% increase from the $5,778,550 generated during the same month last year. Cultivation centers reported $777,696 in sales, compared to $719,733 in October 2025, while manufacturers generated $3,258,936, up 32.3% from $2,462,572 a year earlier.
The number of registered D.C. resident patients continued to climb, reaching 153,828 in October, an increase of 4,629 from September’s 149,199. The number of unique patients served by registered dispensaries also increased, rising from 40,736 to 42,298. The district had 68 licensed retailers in October, up from 67 in September.
D.C. residents accounted for $4,237,980 in dispensary purchases during October, up from $3,938,876 in September. Self-certified temporary patients from outside the district generated another $2,099,301, compared to $1,994,471 the previous month. Patients participating through reciprocity programs contributed $411,575, down slightly from $424,587.
The number of temporary patient registrations also increased, reaching 13,303 in October compared to 12,823 in September. Virginia accounted for the largest number of these registrations at 4,718, followed by Maryland with 1,957, North Carolina with 896, Texas with 634 and Florida with 569.
Flower remained the largest retail product category, generating $3,338,702 from 729 pounds sold, compared to $3,181,101 from 699 pounds in September. Vape cartridges followed at $1,246,163, while infused edibles generated $826,941 and raw pre-rolls accounted for $749,722. Infused concentrates brought in $167,773, while shake and trim generated $98,389.
Marijuana beverage sales also increased substantially, with 2,000 beverages sold for $24,628 in October, compared to 1,014 beverages generating $11,834 in September.
October’s figures mark the sixth month this year that combined medical marijuana sales have exceeded $10 million, with monthly revenue remaining above $9 million since March. With the market approaching $100 million and registered patient enrollment continuing to increase, the district is on track to surpass its full-year 2025 sales total well before the end of 2026.
Related posts:

Massachusetts Marijuana Regulators Say They Have Received No Federal Guidance on DEA Registration Re...

Hawaii Senator Says Federal Marijuana Rescheduling May Remove Barriers to Allowing Medical Marijuana...








